home · filing · 0000950170-24-017881
8-K filed February 21, 2024, 6:59 PM ET
ticker BCAB
CIK 0001826892
other material
confidence high
sentiment neutral
materiality 0.30
BioAtla awards 2023 cash bonuses and RSUs to executives; approves 2024 bonus plan
BioAtla, Inc.
CEO Jay Short receives $419,491 cash bonus for 2023; CFO Waldron $184,718; CMO Sievers $184,338; CAO Vasquez $115,800.
Time-based RSU grants: 417,000 to Short, 106,000 to Waldron, 122,000 to Sievers, 70,000 to Vasquez; vest over 4 years.
Compensation Committee approved 2024 Corporate Bonus Plan; targets: CEO 60%, other officers 40% of base salary.
2024 bonus heavily weighted: 30% clinical milestones, 20% strategic partnerships, 20% financing, 10% R&D, 10% financial/people, 10% brand.
Vasquez promoted to CAO effective Jan 1, 2024; target bonus increased to 40% from 35%.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-01-01
Filed February 21, 2024, 6:59 PM ET
On February 15, 2024, the Compensation Committee approved the promotion of Christian Vasquez from SVP of Finance to Chief Accounting Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christian Vasquez changed role as Chief Accounting Officer, Controller and Corporate Secretary at BioAtla, Inc..
Action promoted
Role Chief Accounting Officer, Controller and Corporate Secretary
Exact text from the filing
On February 15, 2024, the Compensation Committee approved the promotion of Christian Vasquez from SVP of Finance to Chief Accounting Officer.
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-24-017881
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.